Get all your news in one place.
100's of premium titles.
One app.
Start reading
Evening Standard
Evening Standard
World
Michael Howie

Pfizer and BioNTech launch clinical trial for Omicron-specific vaccine

Pfizer has begun a study comparing its original Covid-19 vaccine with doses specially tweaked to match the Omicron variant

(Picture: AP)

Pfizer Inc and BioNTech have announced the start a clinical trial to test a new version of their vaccine specifically designed to target the Omicron variant of Covid-19 Omicron variant.

The highly transmissible strain has eluded some of the protection provided by the original two-dose vaccine regimen.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.